Profilo
Mark Mannebach worked at Santen, Inc. as VP-Global Regulatory Affairs from 2004 to 2008.
From 2008 to 2017, worked at Mallinckrodt Pharmaceuticals as VP-Global Regulatory Affairs.
Also worked at Harrow, Inc. as Head-Regulatory Affairs & Pharmacovigilance.
Held the position of Vice President-Regulatory Affairs at Celcuity, Inc. and Exicure, Inc. Served as Vice President-Global Regulatory Affairs at Eiger BioPharmaceuticals, Inc. Education includes undergraduate studies at Wayne State University (Michigan), graduate studies at the University of Detroit Mercy, and a doctorate from the University of Michigan.
Precedenti posizioni note di Mark Mannebach
| Società | Posizione | Fine |
|---|---|---|
Santen, Inc.
Santen, Inc. Medical SpecialtiesHealth Technology Develops ophthalmic products | Consigliere Generale | 01/11/2008 |
| CELCUITY INC. | Consigliere Generale | - |
| HARROW, INC. | Consigliere Generale | - |
| EXICURE, INC. | Consigliere Generale | - |
Formazione di Mark Mannebach
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Wayne State University (Michigan)
Wayne State University (Michigan) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Detroit Mercy
University of Detroit Mercy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Santen, Inc.
Santen, Inc. Medical SpecialtiesHealth Technology Develops ophthalmic products | Health Technology |
Harrow, Inc.
Harrow, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development, production, and sale of innovative medications | Health Technology |
Celcuity, Inc.
Celcuity, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company develops novel diagnostic tests | Health Technology |
Eiger BioPharmaceuticals, Inc.
Eiger BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat and cure hepatitis delta virus and other serious diseases | Health Technology |
Exicure, Inc.
Exicure, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops nucleic acid therapies against to neurological disorders and hair loss | Health Technology |
















